Compound atlas
Healing

LL-37

Also known as · Cathelicidin

Peptide
Half-life
4h
approx. mean t½
Dose range
100–500 mcg
typical, not prescriptive
Category
Healing
primary use-case
Single-dose decay
t½ = 4h · first-order model
~16h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m4h8h12h16h20h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A human antimicrobial host-defense peptide studied for infection control, wound healing, and biofilm disruption.

Mechanism of action

Directly disrupts microbial membranes and modulates innate immunity and angiogenesis.

Typical protocol

100–500 mcg subQ daily in short cycles.

Storage

Reconstituted: refrigerated, ~30 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.